Integrated DNA Technologies Launches New Archer™ FUSIONPlex™ Core Solid Tumor Panel for Cancer Research

New panel leverages Anchored Multiplex PCR (AMP™) chemistry and Archer Analysis to detect fusions, splice variants and more, enabling downstream application of precision medicine

Patent Issued for AI-Enabled Predictive Risk Rating Capability of Clearwater’s IRM|Analysis® Software

Innovative Application of Artificial Intelligence and Machine Learning Gives Healthcare Organizations Additional Capabilities to Stop Threat Actors by Enabling Them to Make Better Cyber Risk Decisions

CureSearch to fund new cutting-edge study for rare blood cancer in children

Elvin Wagenblast, PhD, of The Tisch Cancer Institute at Mount Sinai, received a CureSearch Young Investigator Award to develop a better understanding of AML in order to guide treatment for patients where standard chemotherapy is ineffective. The study is investigating how a normal blood stem cell can become cancerous. Dr. Wagenblast’s team is using state-of-the-art genome editing to understand vulnerabilities of the disease like never before.

Domainex secures a prestigious King’s Award for Enterprise

Domainex is honoured to announce it has received a King’s Award for Enterprise: International Trade 2023.

Upperton increases oral dosage form capabilities at its Nottingham HQ

Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions (Upperton) has expanded its oral dosage form capabilities at its newly built headquarters in Nottingham, UK.

OM1 Unveils Patented, AI-powered Platform to Accelerate Personalized Medicine

OM1, a real-world data, outcomes, and technology company, launched PhenOM, a new AI solution, which gathers patient data points/phenotypes from structured and unstructured datasets – including clinical notes from messy EHRs – to create unique “fingerprints” for patients based on their medical history. With billions of data points from more than 300 patients, PhenOM is delivering personalized care from life science research to point-of-care clinical decision making.

Tesis Biosciences Announces a Novel Pharmacogenomics Test Enabling Precise, Personalized Response to Wide Range of Pharmaceuticals

Tesis Biosciences Announces a Novel Pharmacogenomics Test Enabling Precise, Personalized Response to Wide Range of Pharmaceuticals

Verana Health Announces the Qdata Parkinson’s Disease Module at 2023 AAN Annual Meeting

Verana Health Announces the Qdata Parkinson’s Disease Module at 2023 AAN Annual Meeting

Results from New Studies Support Role of Digital Tools in Streamlining Dementia Detection; Findings to be Revealed at American Academy of Neurology's Annual Meeting

Linus Health, a digital health company focused on early detection of Alzheimer’s and other dementias, today announced the results of two new studies that further demonstrate the ability of digital cognitive assessments to identify early signs of cognitive impairment and dementia. The findings, which researchers will present at the American Academy of Neurology’s (AAN) 75th Annual Meeting, show that digital, AI-enhanced assessments can play a major role in helping providers efficiently assess older patients’ cognitive function and intervene early in the face of issues - a rising need as new treatments targeting early-stage Alzheimer’s disease become available.

Virscio Deploys Proscia’s Software To Improve Efficiency Of Drug Research And Development

Cloud-based digital pathology platform helps CRO deliver more informed preclinical studies

Creative Biostructure Enhanced Its Thermal Gravimetric Analysis Service

Samsung Biologics Reports First Quarter 2023 Financial Results

Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization (CDMO), today announced financial results for the first quarter of fiscal year 2023.

Peptidoglycan Structure Analysis Now Available at CD BioGlyco

Clearwater Enhances Vendor Cybersecurity Risk Assessment Managed Service Program and CMMC Compliance Certification Capabilities with Cyturus® Software Tools

Clearwater, a cybersecurity and privacy provider, is adopting the Cyturus Third Party Risk Management (TPRM) module of Compliance & Risk Tracker (CRT) as the primary platform for its Vendor Risk Management managed services program, meaning healthcare providers can now better assess and manage third- and fourth-party cybersecurity risk. In 2022, nine of the ten largest healthcare data breaches were caused by third-party vendors. Third-party cybersecurity concerns are consistently cited by Clearwater’s healthcare clients as a key risk to their businesses, leading the company to help solve this challenge by providing an affordable and consistent way of identifying and managing third-party risk.

Twenty Talented Community College Students to Present Research Projects at First Ever Bioscience Workforce Summit

Hello, Thank you for your time. I’m reaching out because I have a story that would definitely interest your readers. On June 26, InnovATEBIO will host 20 talented community college students to present research projects at the first-ever bioscience workforce summit in Washington, DC. According to the Executive Director of InnovATEBIO National Center for Biotechnology Education, Linnea Fletcher, “Envisioning Bioscience will connect students and professionals to create pathways for graduates to enter bioscience careers and achieve their professional goals.” This is a crucial endeavor now that the demand for workers outnumbers the professionals currently employed in the field. Envisioning The Next Bioscience Workforce Summit on Industry Trends and Needs will provide students with opportunities to collaborate with biotech education programs nationwide and network with industry leaders hiring candidates to launch future careers. The students chosen to participate will come from colleges across the country, including: MassBay Community College, Southeast Community College, Valencia College, Austin Community College, Liberal Arts and Sciences Academy High School, Finger Lakes Community College, Bronx Community College, and Montgomery County Community College. Learn more about the summit here. As a platform dedicated to breaking news on global biotechnology, pharmaceuticals, and medical technologies, this story would be perfect for your publication. Thank you,

Cancer Support Community San Francisco Bay Area Launches Initiative to Provide Digital Cancer Care to Underserved Communities

Equiva Healthcare and Cancer Support Community (CSC) San Francisco Bay is announcing the activation of a new initiative to improve access to cancer support and education for those residing in under-connected Bay Area communities. The CSC Bay Area is the second CSC location to launch this program aimed at relieving the inequities and disproportional burden that cancer patients for certain population experience. Digital oncology support resources will be distributed using Equiva's Affordable Connectivity Program(ACP)-centric solution. CSC Bay Area will work with eligible households to enroll them in FCC’s ACP (which provides discounted broadband service) and distribute tablets to patients so they can access important cancer support services and resources.

Three APIs to Meet Market Demands: Tofacitinib Citrate, Tamoxifen Citrate, and Epalrestat

Vaxess Announces Messenger Ribonucleic Acid (mRNA) Stability Results from Tests Assessing the Potential for Room-temperature Storage

Vaxess’s silk fibroin formulations protect mRNA lipid nanoparticles (LNPs) through drying, and maintain in vivo potency after storage at 37°C for two weeks

BOC Sciences Ensures Secure and Rapid Delivery of Isotopically Labeled Materials for Drug Compound Development

BOC Sciences' radiochemists work closely with the worldwide drug compound research teams to deliver high-quality stable isotope labeled products as well as consulting and tailor-made services.

Phastar Supports Great Ormond Street Rare Disease Study Through Pro Bono Scheme

Phastar Supports Great Ormond Street Rare Disease Study Through Pro Bono Scheme Biometrics experts support trial of new treatment for children with severe combined immunodeficiency